ADVB · Advanced Biomed Inc.
Market Cap
$13.06M
Shares
1.38M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$3.26M
-17.1%
FY2025
Diluted EPS
-$3.20
-14.3%
FY2025
Operating Cash Flow
-$5.83M
-173.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| $961.25K | $909.77K | $880.19K | |
| $2.13M | $2.11M | $1.66M | |
| $320.33K | $343.83K | $399.6K | |
| $3.09M | $3.02M | $2.54M | |
| $19.18K | $24.92K | $53.5K | |
| $8M | -$237.93K | -$240.71K | |
| $4.91M | -$3.26M | -$2.78M | |
| $5.28M | -$3.26M | -$2.78M | |
| $4.83M | -$3.04M | -$2.46M | |
| USD/shares | $4.77 | -$3.20 | -$2.80 |
| USD/shares | $4.77 | -$3.20 | -$2.80 |
| shares | — | 1.03M | 1M |
| shares | — | 1.03M | 1M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Key facts
CIK
1941029
CUSIP
00752P203
13F (30d)
2 filings
1 filers